Alixia
Targeting the Tumor Ecosystem to address cancer drug resistance.
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments. Alixia is a Y Combinator company (Winter 2022). YC-listed status: Active.
- Website
- alixia.com
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Alixia — Biopharma research platform developing tumor ecosystem disruptors that target cancer drug resistance across multiple cell types. · Other
Links
- Y Combinator profileycombinator